Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2021-08-24

Link:

https://api.zotero.org/groups/2494380/items/3YFJRYNX?format=atom

Updated:

08/24/2021, 10:26

From feeds:

[sandbox] K4D COVID-19 Resource Hub ยป Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items

Tags:

Authors:

jimwoodhill

Date tagged:

08/24/2021, 10:35

Date published:

08/24/2021, 10:23